Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast cancer survival analysis agents for clinical decision support.
Manzo G, Pannatier Y, Duflot P, Kolh P, Chavez M, Bleret V, Calvaresi D, Jimenez-Del-Toro O, Schumacher M, Calbimonte JP. Manzo G, et al. Among authors: bleret v. Comput Methods Programs Biomed. 2023 Apr;231:107373. doi: 10.1016/j.cmpb.2023.107373. Epub 2023 Jan 25. Comput Methods Programs Biomed. 2023. PMID: 36720187 Free article.
Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study.
Mlakar I, Lin S, Nateqi J, Gruarin S, Diéguez L, Piairo P, Pires LR, Tement S, Aleksandraviča I, Leja M, Arcimoviča K, Bleret V, Kaux JF, Kolh P, Maquet D, Gómez JG, Mata JG, Salgado M, Horvat M, Ravnik M, Flis V, Smrke U. Mlakar I, et al. Among authors: bleret v. J Clin Med. 2022 Apr 5;11(7):2041. doi: 10.3390/jcm11072041. J Clin Med. 2022. PMID: 35407649 Free PMC article.
Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivors.
Mlakar I, Lin S, Aleksandraviča I, Arcimoviča K, Eglītis J, Leja M, Salgado Barreira Á, Gómez JG, Salgado M, Mata JG, Batorek D, Horvat M, Molan M, Ravnik M, Kaux JF, Bleret V, Loly C, Maquet D, Sartini E, Smrke U. Mlakar I, et al. Among authors: bleret v. BMC Med Inform Decis Mak. 2021 Aug 14;21(1):243. doi: 10.1186/s12911-021-01603-w. BMC Med Inform Decis Mak. 2021. PMID: 34391413 Free PMC article.
Should we individualize breast cancer screening?
Desreux J, Bleret V, Lifrange E. Desreux J, et al. Among authors: bleret v. Maturitas. 2012 Nov;73(3):202-5. doi: 10.1016/j.maturitas.2012.08.004. Epub 2012 Sep 14. Maturitas. 2012. PMID: 22981888 Review.
[Hormone therapy for breast cancer].
Lifrange E, Andre C, Bleret V, Collignon J, Coucke P, Cusumano P, Desreux J, Herman P, Jerusalem G, Kridelka F, Martin M, Rorive A, Van Cauwenberge JR, Colin C. Lifrange E, et al. Among authors: bleret v. Rev Med Liege. 2011 May-Jun;66(5-6):367-71. Rev Med Liege. 2011. PMID: 21826978 Free article. French.
[Management of estrogen deficiency after breast cancer].
Desreux J, Bleret V, Pintiaux A, Béliard A, Kridelka F, Lifrange E, Van Cauwenberge JR. Desreux J, et al. Among authors: bleret v. Rev Med Liege. 2011 May-Jun;66(5-6):385-92. Rev Med Liege. 2011. PMID: 21826981 Free article. French.
17 results